Skip to content

Haemonetics HAE Ratios & Valuation

FY'26FY'25FY'24FY'23
Profitability
Gross margin59%+4.0pp55%+2.2pp52.8%+0.2pp52.6%+1.7pp
Free cash flow margin19.5%+9.1pp10.5%
Efficiency
Asset turnover0.6×0.0×0.6×0.0×0.6×0.0×0.6×+0.1×
Inventory turnover1.6×-0.2×1.8×-0.3×2.1×+0.1×+0.4×
Liquidity
Current ratio+1.3×1.6×-0.9×2.6×-0.5×3.1×+1.3×
Quick ratio1.9×+0.9×-0.5×1.5×-0.5×+1.0×
Cash ratio0.9×+0.3×0.5×-0.1×0.6×-0.5×1.1×+0.5×
Leverage
Debt-to-equity1.6×0.0×1.6×+0.7×0.9×-0.1×-0.1×
Debt-to-assets0.5×0.0×0.5×+0.1×0.4×0.0×0.4×0.0×
Per Share
Book value per share$16.82+3.9%$16.18-13.4%$18.68+17.4%$15.91+9.0%
Valuation
Market capitalization$2.62B-18.0%$3.19B-26.3%$4.33B+3.8%$4.17B+29.2%
Enterprise value$3.65B-12.5%$4.17B-17.1%$5.03B+6.6%$4.72B+23.9%
Price / sales-0.4×2.3×-1.0×3.3×-0.3×3.6×+0.3×
Price / book3.3×-0.6×3.9×-0.6×4.5×-0.6×5.1×+0.8×
EV / sales2.7×-0.3×3.1×-0.8×3.8×-0.2×+0.2×
Free cash flow yield9.9%+5.5pp4.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Haemonetics's profit margins?
Haemonetics (HAE) runs a 59.0% gross margin and a 19.0% operating margin, with a 13.3% net margin.
Where do Haemonetics's ratios come from?
Every ratio is computed from Haemonetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.